2019上海生命健康产业投资联盟冬季路演暨临港浦江专场投融资对接会即将开幕

2019-11-19 不详 生物谷

在我国全面推进“健康中国2030”战略,上海建设具有全球影响力的科创中心重点推进生物医药产业发展,生物医药作为闵行区“十三五”重点打造和优先发展的四大战略新兴产业之一的大背景下,为进一步实现产业与资本的深度融合,上海生命健康产业投资联盟联合临港浦江国际科技城,共同举办“2019上海生命健康产业投资联盟冬季路演”暨“临港浦江专场投融资对接会”。 活动将于2019年11月28日下午,在临港浦江国际

在我国全面推进“健康中国2030”战略,上海建设具有全球影响力的科创中心重点推进生物医药产业发展,生物医药作为闵行区“十三五”重点打造和优先发展的四大战略新兴产业之一的大背景下,为进一步实现产业与资本的深度融合,上海生命健康产业投资联盟联合临港浦江国际科技城,共同举办“2019上海生命健康产业投资联盟冬季路演”暨“临港浦江专场投融资对接会”。

活动将于2019年11月28日下午,在临港浦江国际科技城举行。本次路演活动获得闵行区科委、上海市生物医药科技产业促进中心等多方支持,项目涵盖新药研发、生物技术、医疗器械等多个细分领域,欢迎专业投资者及各领域同仁参加!

【活动地点】

上海市闵行区陈行公路2388号,浦江科技广场21号楼B1层报告厅

【活动议程】

13:30-14:00  签到
14:00-14:20  主办方致辞
14:20-15:35  项目路演上半场
15:35-15:45  茶歇
15:45-17:00  项目路演下半场
17:00-17:30  现场交流

【部分项目预览】

项目一:全球创新多特异性抗体药物发现平台

由哈佛医学院James Chou 教授创办。公司基于反向核酸链接技术和纳米抗体技术,实现多个特异性抗体稳定、快速链接,革命性突破三抗、四抗乃至多抗制备的技术难题。动物实验数据显示技术平台已基本稳定,目前针对乳腺癌、胰腺癌等多靶点实体瘤展开侯选抗体筛选,已完成候选抗体的筛选和初步动物实验。

项目二:香港精准医疗项目

由加拿大皇家科学院院士、表观遗传学领军科学家创办,定位于癌症早筛、神经系统疾病早筛与健康管理。公司已分别于香港、广州两地建立实验室,可服务于全球市场;已研发完成15个癌肿早筛产品、2个精神病学早筛产品、1个健康监测产品,大多数为全球独家产品。目前肝癌、宫颈癌、肺癌、结直肠癌早筛产品及生物学年龄检测产品已在香港与知名机构签约销售代理。计划于2021年底前进行香港IPO。

项目三:国内首家辅助生殖试剂企业

创始人拥有20余年辅助生殖行业经验,曾多次担任美、德等国知名生殖中心教授、实验室主任等职位。公司为中国境内首家完全自主研发创新,提供全部配套国产胚胎培养液、卵子、精子处理试剂的供应商。产品集科学家、医生和胚胎学家多年研究成果和临床经验,理想复制了胚胎的自然生长环境(包括输卵管和子宫环境),提供了胚胎最佳生长条件。首个产品系列已于2019年7月获得FDA注册申请。

更多项目确认中,敬请期待……

【主办单位】

闵行区科委主要职能有:宣传贯彻执行有关科技工作的方针、政策和法律、法规、规章,研究制定本区科技发展的有关政策,编制本区科技发展的中长期规划。负责科技园区联络协调,推进产学研合作;负责高新技术企业、科技小巨人企业及科技项目的认定和管理;负责推进科技成果转移转化,提高知识产权应用水平;负责提升全区信息化应用水平;开展科学知识普及;生物医药产业的规划和政策制定,企业服务等。

临港浦江国际科技城兼具国家经济技术开发区、国家高新技术产业开发区和国家综合保税区功能,规划面积10.7平方公里,是上海科创中心建设重要承载区、闵行“国家产城融合示范区”和临港集团重点打造的核心园区之一。园区重点围绕 “生命健康”等5+X的产业进行产业布局和升级,已形成一批有影响力的科技创新龙头企业。截至目前,园区拥有2,600多家各类企业,其中高新技术企业158家、上市企业50余家。

上海生命健康产业投资联盟(简称“投资联盟”)是由“上海市生物医药科技产业促进中心”联合沪上一批专注于生命健康领域的专业投资机构共同发起的专业性组织。联盟秉承“项目互动、资源共享、资本联动”的宗旨,致力于打造接力投资、联合投资的合作平台,推动生命健康产业发展。

【支持单位】

上海市生物医药科技产业促进中心是上海市科学技术委员会直属事业单位,致力于推进上海市生物医药创新体系建设和生物医药成果转化、产业发展。在政府组织下,协调产、学、研、用各方力量,联动区县、高新技术园区、孵化基地、行业协会,制定专项政策规划,搭建生物医药科技创新成果转化与技术交流平台,推动产业快速发展。

【协办单位】

靳诚生物是一家基于医疗器械注册人制度打造的集医疗器械产品技术咨询、工艺转化、中试评估与验证、产品委托生产、企业质量体系建设、临床试验、注册申报、合规化仓储供应链管理、科技金融等多项服务为一体的专业医疗器械CDMO+CRO+CSO第三方一站式综合服务平台,致力于为医疗器械产业化提供从产品研发到上市全生命周期一站式解决方案。

【承办单位】

医科创联是上海市科学技术委员会入库的市级众创空间与上海市生物医药专业化众创空间承担单位,宗旨是助推医疗健康创新项目的产业转化,赋能中小微企业的快速发展。医科创联同时具有投资功能,目前已经完成多个项目的孵化和投资,形成了完整的孵化投资服务体系。

【媒体支持】


【参会报名】

【项目报名】

【联系方式】
mynie@cw-investment.com

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2019158, encodeId=d36f20191588f, content=<a href='/topic/show?id=359f68922cd' target=_blank style='color:#2F92EE;'>#生命健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68922, encryptionId=359f68922cd, topicName=生命健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Jul 05 15:06:00 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741099, encodeId=e9041e4109967, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sat Jan 18 13:06:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459087, encodeId=de68145908e3a, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Thu Nov 21 07:06:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496679, encodeId=7b4a14966e9e0, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Thu Nov 21 07:06:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048129, encodeId=8013104812901, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Tue Nov 19 19:06:00 CST 2019, time=2019-11-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2019158, encodeId=d36f20191588f, content=<a href='/topic/show?id=359f68922cd' target=_blank style='color:#2F92EE;'>#生命健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68922, encryptionId=359f68922cd, topicName=生命健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Jul 05 15:06:00 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741099, encodeId=e9041e4109967, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sat Jan 18 13:06:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459087, encodeId=de68145908e3a, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Thu Nov 21 07:06:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496679, encodeId=7b4a14966e9e0, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Thu Nov 21 07:06:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048129, encodeId=8013104812901, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Tue Nov 19 19:06:00 CST 2019, time=2019-11-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2019158, encodeId=d36f20191588f, content=<a href='/topic/show?id=359f68922cd' target=_blank style='color:#2F92EE;'>#生命健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68922, encryptionId=359f68922cd, topicName=生命健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Jul 05 15:06:00 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741099, encodeId=e9041e4109967, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sat Jan 18 13:06:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459087, encodeId=de68145908e3a, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Thu Nov 21 07:06:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496679, encodeId=7b4a14966e9e0, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Thu Nov 21 07:06:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048129, encodeId=8013104812901, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Tue Nov 19 19:06:00 CST 2019, time=2019-11-19, status=1, ipAttribution=)]
    2019-11-21 zhao4618
  4. [GetPortalCommentsPageByObjectIdResponse(id=2019158, encodeId=d36f20191588f, content=<a href='/topic/show?id=359f68922cd' target=_blank style='color:#2F92EE;'>#生命健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68922, encryptionId=359f68922cd, topicName=生命健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Jul 05 15:06:00 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741099, encodeId=e9041e4109967, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sat Jan 18 13:06:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459087, encodeId=de68145908e3a, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Thu Nov 21 07:06:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496679, encodeId=7b4a14966e9e0, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Thu Nov 21 07:06:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048129, encodeId=8013104812901, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Tue Nov 19 19:06:00 CST 2019, time=2019-11-19, status=1, ipAttribution=)]
    2019-11-21 zexyw04
  5. [GetPortalCommentsPageByObjectIdResponse(id=2019158, encodeId=d36f20191588f, content=<a href='/topic/show?id=359f68922cd' target=_blank style='color:#2F92EE;'>#生命健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68922, encryptionId=359f68922cd, topicName=生命健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Jul 05 15:06:00 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741099, encodeId=e9041e4109967, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sat Jan 18 13:06:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459087, encodeId=de68145908e3a, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Thu Nov 21 07:06:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496679, encodeId=7b4a14966e9e0, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Thu Nov 21 07:06:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048129, encodeId=8013104812901, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Tue Nov 19 19:06:00 CST 2019, time=2019-11-19, status=1, ipAttribution=)]
    2019-11-19 CHANGE

    又是钱!医学需要投资呀,赞!

    0

相关资讯

盘点:2014造福社会的14项创新,生命健康6项

2014年接近尾声,一起来细数今年又出现了哪些可能改变生活、造福人类的发明吧。 1. ReSound LiNX助听器 于今年二月世界移通信大会上推出的ReSound LiNX助听器是一款可与iPhone蓝牙连接的辅助听力设备。佩戴者能用手机调节音量大小,动作不易察觉,以避免引起尴尬。该设备借助ReSound App记录应用数据,为佩戴者提供更加精确的个性化服务,比如根据不同的环境地点提

今年政府工作报告提出:坚决守住人民群众生命健康的防线

3月5日,十三届全国人大二次会议在京开幕。